New non-invasive option for colon cancer screening
The Cologuard tests stool samples for abnormal DNA. The test was 92-percent effective at catching cancer, and 42-percent effective at finding pre-cancerous polyps. CBS News chief medical correspondent Dr. Jon LaPook explains.